ERK1/2 inhibitor 5
ERK1/2 inhibitor 5 is a potent inhibitor of ERK1/2. Mitogen-activated protein kinase (MAPK) plays an extremely important role in the signal transduction pathway, and extracellular signal regulated kinase (ERK) is a member of the MAPK family. ERK1/2 inhibitor 5 has the potential for the research or prevention of cancer, inflammation or other proliferative diseases (extracted from patent WO2020238776A1) [1].
Product Specifications
CAS Number
2560552-75-0
UNSPSC
12352005
Target
ERK
Type
Reference compound
Related Pathways
MAPK/ERK Pathway; Stem Cell/Wnt
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/erk1-2-inhibitor-5.html
Solubility
10 mM in DMSO
Smiles
O=C1N2C(CCN1[C@H](C)C(N[C@@H](C3=CC(OC)=CC(F)=C3)CO)=O)=CC(C4=NC(NC5CCOCC5)=NC=C4Cl)=C2
Molecular Formula
C28H32ClFN6O5
Molecular Weight
587.04
References & Citations
[1]Xin Li, et al. Substituted condensed bicyclic derivatives, their preparation method and their application in medicine. Patent WO2020238776A1.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Cytokeratin, LMW (AE-1), CF594 conjugate, 0.1mg/mL
Mucin 5AC (MUC5AC) (45M1), CF568 conjugate, 0.1mg/mL
